Bridgeway Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-31,900
| Closed | -$119K | – | 1328 |
|
|
2024
Q3 | $119K | Hold |
31,900
| – | – | ﹤0.01% | 1137 |
|
|
2024
Q2 | $179K | Hold |
31,900
| – | – | ﹤0.01% | 1075 |
|
|
2024
Q1 | $167K | Hold |
31,900
| – | – | ﹤0.01% | 1136 |
|
|
2023
Q4 | $167K | Buy |
+31,900
| New | +$167K | ﹤0.01% | 1173 |
|
|
2018
Q3 | – | Sell |
-6,600
| Closed | -$499K | – | 1484 |
|
|
2018
Q2 | $499K | Hold |
6,600
| – | – | 0.01% | 1130 |
|
|
2018
Q1 | $348K | Hold |
6,600
| – | – | ﹤0.01% | 1171 |
|
|
2017
Q4 | $353K | Hold |
6,600
| – | – | ﹤0.01% | 1176 |
|
|
2017
Q3 | $394K | Hold |
6,600
| – | – | ﹤0.01% | 1150 |
|
|
2017
Q2 | $521K | Buy |
+6,600
| New | +$521K | 0.01% | 1082 |
|
|
2015
Q4 | – | Sell |
-15,150
| Closed | -$1.12M | – | 1503 |
|
|
2015
Q3 | $1.12M | Sell |
15,150
-16,968
| -53% | -$1.26M | 0.02% | 700 |
|
|
2015
Q2 | $2.6M | Buy |
32,118
+150
| +0.5% | +$12.1K | 0.05% | 424 |
|
|
2015
Q1 | $1.34M | Hold |
31,968
| – | – | 0.03% | 675 |
|
|
2014
Q4 | $496K | Buy |
31,968
+15,000
| +88% | +$233K | 0.01% | 1068 |
|
|
2014
Q3 | $215K | Buy |
+16,968
| New | +$215K | 0.01% | 1328 |
|